Evidence map›Paper›PMID 35887162›Full record

ArticleInternational journal of molecular sciences2022

Modelling the Human Blood-Brain Barrier in Huntington Disease.

Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Antonella Cellucci, Giulio Auciello, Maria Rosaria Battista, Isabelle Gloaguen, Silvia Fortuni, Cristina Cariulo, Vinod Khetarpal and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. From Genetics to Function: the Role of ABCA12 in Autism Neurobiology.Journal of molecular neuroscience : MN · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Domenico VignoneIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Odalys Gonzalez PazIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Ivan FiniIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Antonella CellucciIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Giulio AucielloIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.ORCID 0000-0003-3494-167X
Maria Rosaria BattistaIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Isabelle GloaguenIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.ORCID 0000-0001-5083-5098
Silvia FortuniIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Cristina CariuloIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Vinod KhetarpalCHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA.
Celia DominguezCHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA.
Ignacio Muñoz-SanjuánCHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA.ORCID 0000-0003-0353-3577
Annalise Di MarcoIRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.ORCID 0000-0001-5211-6230

Funding

CHDI Foundation na
6 · The paper itself

Abstract

While blood-brain barrier (BBB) dysfunction has been described in neurological disorders, including Huntington's disease (HD), it is not known if endothelial cells themselves are functionally compromised when promoting BBB dysfunction. Furthermore, the underlying mechanisms of BBB dysfunction remain elusive given the limitations with mouse models and post mortem tissue to identify primary deficits. We established models of BBB and undertook a transcriptome and functional analysis of human induced pluripotent stem cell (iPSC)-derived brain-like microvascular endothelial cells (iBMEC) from HD patients or unaffected controls. We demonstrated that HD-iBMECs have abnormalities in barrier properties, as well as in specific BBB functions such as receptor-mediated transcytosis.

Indexed as

Huntington DiseaseInduced Pluripotent Stem CellsAnimalsBlood-Brain BarrierCell DifferentiationEndothelial CellsHumansMiceblood–brain barrierbrain endothelial cellsHuntington’s diseaseinduced pluripotent stem cellsin vitro modelstransport

Identifiers

PMID35887162
PMCPMC9321930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.